Search

Nathan J. Milakovich

Examiner (ID: 7093, Phone: (571)270-3087 , Office: P/2848 )

Most Active Art Unit
2848
Art Unit(s)
2835, 4134, 2848, 2847
Total Applications
953
Issued Applications
727
Pending Applications
69
Abandoned Applications
167

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19081819 [patent_doc_number] => 20240108620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => Treatment Regimen [patent_app_type] => utility [patent_app_number] => 18/509964 [patent_app_country] => US [patent_app_date] => 2023-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18509964 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/509964
Treatment Regimen Nov 14, 2023 Pending
Array ( [id] => 18709259 [patent_doc_number] => 20230331873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => METHOD FOR MODIFYING POLYSACCHARIDE MATERIAL BY SEQUENCED HOMOGENEOUS CHEMICAL FUNCTIONALISATION [patent_app_type] => utility [patent_app_number] => 18/113772 [patent_app_country] => US [patent_app_date] => 2023-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18113772 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/113772
METHOD FOR MODIFYING POLYSACCHARIDE MATERIAL BY SEQUENCED HOMOGENEOUS CHEMICAL FUNCTIONALISATION Feb 23, 2023 Abandoned
Array ( [id] => 18269193 [patent_doc_number] => 20230090435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => Compounds with Antimicrobial Properties [patent_app_type] => utility [patent_app_number] => 18/056346 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056346 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/056346
Method of treating Gram-negative bacterial infection with isolated darobactin compounds Nov 16, 2022 Issued
Array ( [id] => 18724278 [patent_doc_number] => 20230338412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => METHOD OF USING CYCLODEXTRIN [patent_app_type] => utility [patent_app_number] => 17/949672 [patent_app_country] => US [patent_app_date] => 2022-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17949672 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/949672
METHOD OF USING CYCLODEXTRIN Sep 20, 2022 Abandoned
Array ( [id] => 18530243 [patent_doc_number] => 20230235313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => METHOD FOR SEPARATING NUCLEIC ACID AMPLIFICATION SYSTEM, AND SEPARATOR [patent_app_type] => utility [patent_app_number] => 18/019825 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019825 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/019825
METHOD FOR SEPARATING NUCLEIC ACID AMPLIFICATION SYSTEM, AND SEPARATOR Feb 10, 2022 Abandoned
Array ( [id] => 18784754 [patent_doc_number] => 20230372381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => COMPOSITIONS AND METHODS UTILIZING PROTEIN INHIBITORS FOR SYNERGISTIC INHIBITION AND TREATMENT OF SARS-CoV-2 [patent_app_type] => utility [patent_app_number] => 18/030366 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030366 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030366
COMPOSITIONS AND METHODS UTILIZING PROTEIN INHIBITORS FOR SYNERGISTIC INHIBITION AND TREATMENT OF SARS-CoV-2 Oct 4, 2021 Pending
Array ( [id] => 18895528 [patent_doc_number] => 20240011013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => NUCLEIC ACID PURIFICATION METHOD, NUCLEIC ACID EXTRACTION LIQUID, AND NUCLEIC ACID PURIFICATION KIT [patent_app_type] => utility [patent_app_number] => 18/024322 [patent_app_country] => US [patent_app_date] => 2021-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7661 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024322 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/024322
NUCLEIC ACID PURIFICATION METHOD, NUCLEIC ACID EXTRACTION LIQUID, AND NUCLEIC ACID PURIFICATION KIT Sep 2, 2021 Pending
Array ( [id] => 18707550 [patent_doc_number] => 20230330126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => MODIFIED ADENOSINE NUCLEOSIDE FOR USE IN THE TREATMENT OF VIRAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/003984 [patent_app_country] => US [patent_app_date] => 2021-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7356 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003984 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003984
MODIFIED ADENOSINE NUCLEOSIDE FOR USE IN THE TREATMENT OF VIRAL INFECTIONS Jun 27, 2021 Pending
Array ( [id] => 18610810 [patent_doc_number] => 20230277540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => Treatment of Dilated Cardiomyopathies [patent_app_type] => utility [patent_app_number] => 18/009034 [patent_app_country] => US [patent_app_date] => 2021-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13292 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009034 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/009034
Treatment of Dilated Cardiomyopathies Jun 8, 2021 Abandoned
Array ( [id] => 18656152 [patent_doc_number] => 20230302031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => Modulators Of Purinergic Receptors and Related Immune Checkpoint For Treating Acute Respiratory Distress Syndrome [patent_app_type] => utility [patent_app_number] => 17/928352 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25763 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928352 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/928352
Modulators Of Purinergic Receptors and Related Immune Checkpoint For Treating Acute Respiratory Distress Syndrome May 31, 2021 Abandoned
Array ( [id] => 18374292 [patent_doc_number] => 20230149370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY [patent_app_type] => utility [patent_app_number] => 17/915120 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5159 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915120 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/915120
USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY Mar 25, 2021 Pending
Array ( [id] => 20729015 [patent_doc_number] => 12636259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-26 [patent_title] => Transdermal absorption preparation [patent_app_type] => utility [patent_app_number] => 17/904577 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12811 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904577 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/904577
Transdermal absorption preparation Feb 17, 2021 Issued
Array ( [id] => 16790999 [patent_doc_number] => 20210120816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => SURFACE STERILISATION BY MISTING WITH A BIOFLAVANOID SOLUTION [patent_app_type] => utility [patent_app_number] => 17/091733 [patent_app_country] => US [patent_app_date] => 2020-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091733 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/091733
SURFACE STERILISATION BY MISTING WITH A BIOFLAVANOID SOLUTION Nov 5, 2020 Abandoned
Array ( [id] => 18057914 [patent_doc_number] => 20220389000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/761402 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52334 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 482 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761402 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761402
PESTICIDALLY ACTIVE CYCLIC AMINE COMPOUNDS Sep 17, 2020 Pending
Array ( [id] => 18034601 [patent_doc_number] => 20220378816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => 2-BENZYLIDENE HYDRAZINOADENOSINE COMPOUNDS HAVING A2A ADENOSINE RECEPTOR AGONISTIC ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/621019 [patent_app_country] => US [patent_app_date] => 2020-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9731 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17621019 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/621019
2-BENZYLIDENE HYDRAZINOADENOSINE COMPOUNDS HAVING A2A ADENOSINE RECEPTOR AGONISTIC ACTIVITY Jun 21, 2020 Abandoned
Array ( [id] => 17503417 [patent_doc_number] => 20220096519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING SPRAY DRIED VITAMIN B12 [patent_app_type] => utility [patent_app_number] => 17/619467 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17619467 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/619467
SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING SPRAY DRIED VITAMIN B12 Jun 16, 2020 Abandoned
Array ( [id] => 17944331 [patent_doc_number] => 20220331348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => METHOD OF PREPARING PENTACYCLIC TRITERPENOID SAPONINS AND DRUG COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/616690 [patent_app_country] => US [patent_app_date] => 2020-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616690 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/616690
METHOD OF PREPARING PENTACYCLIC TRITERPENOID SAPONINS AND DRUG COMPOSITION May 28, 2020 Abandoned
Array ( [id] => 17670836 [patent_doc_number] => 20220184003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => Formulations of Cannabidiol Derivatives and Their Use as Modulators of Cannabinoid Receptor Type 2 (CB2) [patent_app_type] => utility [patent_app_number] => 17/428929 [patent_app_country] => US [patent_app_date] => 2020-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29829 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428929 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428929
Formulations of Cannabidiol Derivatives and Their Use as Modulators of Cannabinoid Receptor Type 2 (CB2) Feb 5, 2020 Pending
Array ( [id] => 17170231 [patent_doc_number] => 20210323901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => METHOD OF STORING AND/OR TRANSPORTING OXO ALCOHOL [patent_app_type] => utility [patent_app_number] => 17/260175 [patent_app_country] => US [patent_app_date] => 2019-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260175 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/260175
METHOD OF STORING AND/OR TRANSPORTING OXO ALCOHOL Jul 21, 2019 Abandoned
Array ( [id] => 16793058 [patent_doc_number] => 20210122875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => Cross-linked Nanoporous Saccharide-based Material and Methods for Fabrication Thereof [patent_app_type] => utility [patent_app_number] => 17/259203 [patent_app_country] => US [patent_app_date] => 2019-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7393 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 278 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259203 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/259203
Cross-linked Nanoporous Saccharide-based Material and Methods for Fabrication Thereof Jul 9, 2019 Abandoned
Menu